Literature DB >> 17075562

Malignant pleural mesothelioma: a comprehensive review.

Roohi Ismail-Khan1, Lary A Robinson, Charles C Williams, Christopher R Garrett, Gerold Bepler, George R Simon.   

Abstract

BACKGROUND: The incidence of malignant mesothelioma continues to increase, but the disease remains difficult to detect early and treat effectively.
METHODS: The authors review the pathogenesis, incidence, clinical presentation, diagnosis, pathology, and both standard and experimental treatments for mesothelioma.
RESULTS: When possible, surgery (video-assisted thoracoscopy, pleurectomy/decortication, or extrapleural pneumonectomy) is utilized. Effects on underlying structures limit application of radiation therapy, but some systemic agents are beginning to enhance survival.
CONCLUSIONS: The disease is expected to increase in incidence till 2020, so awareness of this entity as a possible diagnosis should be heightened. In patients with advanced disease, several newer antitumor agents are already showing a capability of extending survival so it is not unreasonable to expect further progress in this area.

Entities:  

Mesh:

Year:  2006        PMID: 17075562     DOI: 10.1177/107327480601300402

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  55 in total

Review 1.  The Role of Regulatory T Cells in Mesothelioma.

Authors:  Demelza J Ireland; Haydn T Kissick; Manfred W Beilharz
Journal:  Cancer Microenviron       Date:  2012-02-01

2.  Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma.

Authors:  Carmina Jiménez-Ramírez; Swaantje Casjens; Cuauhtémoc Arturo Juárez-Pérez; Irina Raiko; Luz M Del Razo; Dirk Taeger; Emma S Calderón-Aranda; Hans-Peter Rihs; Leonor Concepción Acosta-Saavedra; Daniel Gilbert Weber; Alejandro Cabello-López; Beate Pesch; María Dolores Ochoa-Vázquez; Katarzyna Burek; Luis Torre-Bouscoulet; José Rogelio Pérez-Padilla; Erik Marco García-Bazan; Thomas Brüning; Georg Johnen; Guadalupe Aguilar-Madrid
Journal:  Lung       Date:  2019-07-02       Impact factor: 2.584

3.  Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus.

Authors:  S Kubo; M Takagi-Kimura; C R Logg; N Kasahara
Journal:  Cancer Gene Ther       Date:  2013-11-08       Impact factor: 5.987

Review 4.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

Review 5.  Role of microRNAs in malignant mesothelioma.

Authors:  A Truini; S Coco; A Alama; C Genova; C Sini; M G Dal Bello; G Barletta; E Rijavec; G Burrafato; F Boccardo; F Grossi
Journal:  Cell Mol Life Sci       Date:  2014-02-23       Impact factor: 9.261

6.  A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma.

Authors:  Craig W Menges; Yibai Chen; Brooke T Mossman; Jonathan Chernoff; Anthony T Yeung; Joseph R Testa
Journal:  Genes Cancer       Date:  2010-05-01

7.  Diffuse malignant pleural mesothelioma: a multi-institutional clinicopathological study.

Authors:  Akira Iyoda; Toshikazu Yusa; Chikabumi Kadoyama; Kazuyoshi Sasaki; Hideki Kimura; Hisami Yamakawa; Mitsutoshi Shiba; Takehiko Fujisawa; Ichiro Yoshino
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

8.  In vitro and in vivo characterization of highly purified human mesothelioma derived cells.

Authors:  Alice Melotti; Antonio Daga; Daniela Marubbi; Annalisa Zunino; Luciano Mutti; Giorgio Corte
Journal:  BMC Cancer       Date:  2010-02-22       Impact factor: 4.430

9.  High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma.

Authors:  Elisa Mazzoni; Alfredo Corallini; Alfonso Cristaudo; Angelo Taronna; Gianfranco Tassi; Marco Manfrini; Manola Comar; Massimo Bovenzi; Roberto Guaschino; Francesca Vaniglia; Corrado Magnani; Ferruccio Casali; Giovanni Rezza; Giuseppe Barbanti-Brodano; Fernanda Martini; Mauro G Tognon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

10.  Combined bias suppression in single-arm therapy studies.

Authors:  Harald J Hamre; Anja Glockmann; Gunver S Kienle; Helmut Kiene
Journal:  J Eval Clin Pract       Date:  2008-03-24       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.